These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 22091596)

  • 1. Pathways towards an effective immunotherapy for Parkinson's disease.
    Hutter-Saunders JA; Mosley RL; Gendelman HE
    Expert Rev Neurother; 2011 Dec; 11(12):1703-15. PubMed ID: 22091596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders.
    Machhi J; Kevadiya BD; Muhammad IK; Herskovitz J; Olson KE; Mosley RL; Gendelman HE
    Mol Neurodegener; 2020 Jun; 15(1):32. PubMed ID: 32503641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases.
    Kosloski LM; Ha DM; Hutter JA; Stone DK; Pichler MR; Reynolds AD; Gendelman HE; Mosley RL
    J Neurochem; 2010 Sep; 114(5):1261-76. PubMed ID: 20524958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and adaptive immunity in Parkinson's disease.
    Mosley RL; Hutter-Saunders JA; Stone DK; Gendelman HE
    Cold Spring Harb Perspect Med; 2012 Jan; 2(1):a009381. PubMed ID: 22315722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization strategies for Parkinson's disease.
    Ha D; Stone DK; Mosley RL; Gendelman HE
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S218-21. PubMed ID: 22166440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation in neurodegenerative diseases.
    Amor S; Puentes F; Baker D; van der Valk P
    Immunology; 2010 Feb; 129(2):154-69. PubMed ID: 20561356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for neurodegeneration?
    Liu Y; Aguzzi A
    Science; 2019 Apr; 364(6436):130-131. PubMed ID: 30975878
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.
    Valera E; Spencer B; Masliah E
    Neurotherapeutics; 2016 Jan; 13(1):179-89. PubMed ID: 26494242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders.
    Gendelman HE; Mosley RL
    J Neuroimmune Pharmacol; 2015 Dec; 10(4):645-50. PubMed ID: 26520433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease.
    Gelders G; Baekelandt V; Van der Perren A
    J Immunol Res; 2018; 2018():4784268. PubMed ID: 29850629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing the immune system for the treatment of Parkinson's disease.
    Vedam-Mai V
    Brain Res; 2021 May; 1758():147308. PubMed ID: 33524380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The innate and adaptive immunological aspects in neurodegenerative diseases.
    Rodrigues MC; Sanberg PR; Cruz LE; Garbuzova-Davis S
    J Neuroimmunol; 2014 Apr; 269(1-2):1-8. PubMed ID: 24161471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-directed gene therapeutic development for Alzheimer's, prion, and Parkinson's diseases.
    Maguire-Zeiss KA; Federoff HJ
    J Neuroimmune Pharmacol; 2009 Sep; 4(3):298-308. PubMed ID: 18931916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic strategies for neurodegenerative disorders: emerging clues from Parkinson's disease.
    Bjarkam CR; Sørensen JC
    Biol Psychiatry; 2004 Aug; 56(4):213-6. PubMed ID: 15312807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.
    Neff F; Wei X; Nölker C; Bacher M; Du Y; Dodel R
    Autoimmun Rev; 2008 Jun; 7(6):501-7. PubMed ID: 18558370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Antibodies and Their Receptors in Protection Against Ordered Protein Assembly in Neurodegeneration.
    Katsinelos T; Tuck BJ; Mukadam AS; McEwan WA
    Front Immunol; 2019; 10():1139. PubMed ID: 31214163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.
    Olson KE; Gendelman HE
    Curr Opin Pharmacol; 2016 Feb; 26():87-95. PubMed ID: 26571205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New strategies for the treatment of Parkinson's disease hold considerable promise for the future management of neurodegenerative disorders.
    Bjarkam CR; Sørensen JC; Sunde NA; Geneser FA; Ostergaard K
    Biogerontology; 2001; 2(3):193-207. PubMed ID: 11708721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies.
    Rockenstein E; Ostroff G; Dikengil F; Rus F; Mante M; Florio J; Adame A; Trinh I; Kim C; Overk C; Masliah E; Rissman RA
    J Neurosci; 2018 Jan; 38(4):1000-1014. PubMed ID: 29246926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.